Current Radiopharmaceuticals

Editor-in-Chief

Sean L. Kitson
Department of Biocatalysis and Isotope Chemistry Almac Sciences
Almac House
Craigavon
(Northern Ireland)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor



The Imaging of Lung Cancer: A Complete Vision free to download

Volume:13   Issue: 3
Pp: 165-165
Luigi Mansi and Laura Evangelista
DOI: 10.2174/187447101303201029121009
Published on: 30 November, 2020



99mTc-EDDA/HYNIC-TOC is a New Opportunity in Neuroendocrine Tumors of the Lung (and in other Malignant and Benign Pulmonary Diseases) open access plus

Volume:13   Issue: 3
Pp: 166-176
Vittorio Briganti, Vincenzo Cuccurullo*, Valentina Berti, Giuseppe D. Di Stasio, Flavia Linguanti, Francesco Mungai and Luigi Mansi
DOI: 10.2174/1874471013666191230143610
Published on: 30 November, 2020




PET/CT and the Response to Immunotherapy in Lung Cancer open access plus

Volume:13   Issue: 3
Pp: 177-184
Laura Evangelista*, Matteo Sepulcri and Giulia Pasello
DOI: 10.2174/1874471013666191220105449
Published on: 30 November, 2020




Alternative and New Radiopharmaceutical Agents for Lung Cancer open access plus

Volume:13   Issue: 3
Pp: 185-194
Silvi Telo*, Letizia Calderoni, Sara Vichi, Federico Zagni, Paolo Castellucci and Stefano Fanti
DOI: 10.2174/1874471013666191223151402
Published on: 30 November, 2020




FDG PET/CT in the Staging of Lung Cancer open access plus

Volume:13   Issue: 3
Pp: 195-203
Mohsen Farsad*
DOI: 10.2174/1874471013666191223153755
Published on: 30 November, 2020




Radiotherapy Planning and Molecular Imaging in Lung Cancer open access plus

Volume:13   Issue: 3
Pp: 204-217
Angelina Filice*, Massimiliano Casali, Patrizia Ciammella, Marco Galaverni, Federica Fioroni, Cinzia Iotti and Annibale Versari
DOI: 10.2174/1874471013666200318144154
Published on: 30 November, 2020




Respiratory Gating and the Performance of PET/CT in Pulmonary Lesions open access plus

Volume:13   Issue: 3
Pp: 218-227
Cinzia Crivellaro and Luca Guerra*
DOI: 10.2174/1874471013666200317144629
Published on: 30 November, 2020




18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the Art open access plus

Volume:13   Issue: 3
Pp: 228-237
Angelo Castello , Sabrina Rossi and Egesta Lopci *
DOI: 10.2174/1874471013666191230144821
Published on: 30 November, 2020




Lung Cancer and Radiological Imaging open access plus

Volume:13   Issue: 3
Pp: 238-242
Annalori Panunzio* and Paolo Sartori
DOI: 10.2174/1874471013666200523161849
Published on: 30 November, 2020




The Multicenter Italian Trial Assesses the Performance of FDG-PET /CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic Strategy open access plus

Volume:13   Issue: 3
Pp: 243-248
Marco Spadafora*, Laura Evangelista, Salvatore Fiordoro, Francesco Porcaro, Marilena Sicignano and Luigi Mansi
DOI: 10.2174/1874471013666200318142210
Published on: 30 November, 2020




Acknowledgements to Reviewers free to download

Volume:13   Issue: 3
Pp: 249-249

DOI: 10.2174/187447101303201029120845
Published on: 30 November, 2020